tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Compugen Ltd. Announces 2025 Annual General Meeting Details
PremiumCompany AnnouncementsCompugen Ltd. Announces 2025 Annual General Meeting Details
2M ago
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
Premium
Company Announcements
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials
2M ago
Compugen reports Q2 EPS (8c), consensus (9c)
Premium
The Fly
Compugen reports Q2 EPS (8c), consensus (9c)
2M ago
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
PremiumCompany AnnouncementsCompugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment?
3M ago
Compugen’s Long-Term Value Potential: Buy Rating Backed by AstraZeneca Partnerships and Financial Stability
Premium
Ratings
Compugen’s Long-Term Value Potential: Buy Rating Backed by AstraZeneca Partnerships and Financial Stability
4M ago
Compugen’s Q1 2025: Clinical Progress and Financial Stability
Premium
Company Announcements
Compugen’s Q1 2025: Clinical Progress and Financial Stability
5M ago
Compugen Announces Leadership Changes Effective September 2025
PremiumCompany AnnouncementsCompugen Announces Leadership Changes Effective September 2025
5M ago
Compugen appoints Eran Ophir as CEO, announces leadership transitions
Premium
The Fly
Compugen appoints Eran Ophir as CEO, announces leadership transitions
5M ago
Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability
Premium
Company Announcements
Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100